UNITED STATES

SECURITIES AND EXCHANGE COMMISSION


Washington, DC 20549

___________

 

FORM 8-K

___________

 

CURRENT REPORT

 

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

Date of Report (Date Of Earliest Event Reported): December 5, 2011



TOTAL NUTRACEUTICAL SOLUTIONS, INC.

 (Exact name of registrant as specified in charter)

 

Commission File Number:  000-53493

 

Nevada

 

26-0561199

(State or other jurisdiction of

incorporation or organization)

 

(I.R.S. Employer Identification No.)


80 Columbia Street

Stevenson, Washington

 

98648

(Address of principal executive offices)

 

(Zip Code)


(509) 427-5132

(Registrant’s telephone number, including area code)

 

 

(Former name or former address, if changed since last report)


  

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

[  ]   Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

[  ]   Soliciting material pursuant to Rule 14a-12 under the Exchange Act(17CFR240.14a-12)

[  ]   Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act(17CFR240.14d-2(b))

[  ]   Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act(17CFR240.13e-4(c))

  



Item 8.01  Other Events.


On December 5, 2011 Total Nutraceutical Solutions, Inc. (TNS) announced that it had obtained approval from the Financial Industry Regulatory Authority or FINRA for the change in its trading symbol on the OTC Bulletin Board from “TNUS.OB” to “ERGO.OB.”  The change was effective on Monday, December 5.


On December 7, 2011 TNS announced that its patent application No. 2,680,223, “Use of Ergothioneine as a Preservative in Foods and Beverages” has been allowed in Canada.  The patent claims include but are not limited to a method of preserving a food, beverage or medicine with L-Ergothioneine (Ergo), where Ergo replaces an antioxidant composition, antimicrobial composition, and/or sulfur dioxide preservatives.  The use claims under the patent apply to the preservation of canned, frozen, dried, or fresh fruits, vegetables, red and white wine, beer, baked goods, fruit juices, butter, meats, pet foods, cosmetics, medicines, and even petroleum and rubber products.  Similar patent applications are pending in the United States and the European Union.


                                                                                                     

Item 9.01

Financial Statements and Exhibits.


     (d)  Exhibits.


 

Exhibit #

Description

 

None.

 


  

SIGNATURES

  

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.


  

  

  

  

  

TOTAL NUTRACEUTICAL SOLUTIONS, INC.

(Registrant)

 

 

 

 

Date:  December 8, 2011

  

  

  

By:

  

/s/ Marvin S. Hausman, M.D.

  

  

  

  

  

  

  

  

Marvin S. Hausman, M.D.

President and CEO